Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. Their innovative approach involves targeting specific receptors in the brain to treat conditions such as depression, Alzheimer’s disease, and migraines. Through their dedication to research and development, Axsome Therapeutics aims to improve the lives of patients suffering from these debilitating conditions.
Notification